Search research articles
Contact Us
Filters
Showing results (941-950 of 1,023) with videos related to
Page
of 103
Sort By:
American Heart Journal
|
June 6, 2020
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
Renato D Lopes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros E Silva, et al.
Circulation
|
July 17, 2023
Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry
Asishana Osho, Marcelo F Fernandes, Ram Poudel, et al.
American Heart Journal
|
May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
Warren J Cantor, Mary Tan, Otavio Berwanger, et al.
JAMA Cardiology
|
September 29, 2018
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial
Renato D Lopes, Pedro G M de Barros E Silva, Isabella de Andrade Jesuíno, et al.
Journal of Cardiac Failure
|
April 18, 2025
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Eugene Braunwald, et al.
Lancet (London, England)
|
June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
L Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Journal of the American Heart Association
|
November 26, 2020
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation
Frederik Dalgaard, Haolin Xu, Roland A Matsouaka, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
NEJM Evidence
|
May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation
Satoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Page
of 103
Search research articles
Search
Showing results (941-950 of 1,023) with videos related to
Sort By:
Page
of 103
American Heart Journal
|
June 6, 2020
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
Renato D Lopes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros E Silva, et al.
Circulation
|
July 17, 2023
Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry
Asishana Osho, Marcelo F Fernandes, Ram Poudel, et al.
American Heart Journal
|
May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
Warren J Cantor, Mary Tan, Otavio Berwanger, et al.
JAMA Cardiology
|
September 29, 2018
Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial
Renato D Lopes, Pedro G M de Barros E Silva, Isabella de Andrade Jesuíno, et al.
Journal of Cardiac Failure
|
April 18, 2025
NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Eugene Braunwald, et al.
Lancet (London, England)
|
June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial
L Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Journal of the American Heart Association
|
November 26, 2020
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation
Frederik Dalgaard, Haolin Xu, Roland A Matsouaka, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
NEJM Evidence
|
May 26, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation
Satoshi Shoji, Pishoy Gouda, Caroline A Falvey, et al.
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Page
of 103